Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Multicenter, Randomized, Open-Label, Positive Controlled Phase III Study to Evaluate the Efficacy and Safety of VSA012 Injection in Participants With Paroxysmal Nocturnal Hemoglobinuria Who Are Naive to Complement Inhibitor TherapyHemic and Lymphatic Diseases, Hemoglobinuria, Paroxysmal, anemia, bone marrow disorder, hematologic disorder, hemolytic anemia, myelodysplastic syndromeNot yet recruitingPhase 32026-09-11NCT07816237

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Bisirna Therapeutics (Suzhou) Co., Ltd.3

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
ChangshaChangshaChina1
ChengduChengduChina1
GuangzhouGuangzhouChina1
Ha'erbinHarbinChina1
Institute of Hematology, Chinese Academy of Medical SciencesTianjinChina2
JilinJilin CityChina1
NanningNanningChina1
NantongNantongChina1
Peking Union Medical College HospitalBeijingChina48
QuanzhouQuanzhouChina1
The First Affiliated Hospital of Zhejiang University School of MedicineHangzhouChina18
WuhanWuhanChina1
Xi'anXi’anChina1
ZhengzhouZhengzhouChina1